Growth Metrics

TransMedics (TMDX) Non-Current Deffered Revenue (2018 - 2021)

TransMedics has reported Non-Current Deffered Revenue over the past 4 years, most recently at $1.6 million for Q3 2021.

  • Quarterly results put Non-Current Deffered Revenue at $1.6 million for Q3 2021, changed 0.43% from a year ago — trailing twelve months through Sep 2021 was $1.6 million (changed 0.43% YoY), and the annual figure for FY2020 was $1.6 million, up 311.05%.
  • Non-Current Deffered Revenue for Q3 2021 was $1.6 million at TransMedics, up from $1.5 million in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for TMDX hit a ceiling of $3.4 million in Q4 2018 and a floor of $389000.0 in Q4 2019.
  • Median Non-Current Deffered Revenue over the past 4 years was $1.5 million (2021), compared with a mean of $1.3 million.
  • Biggest five-year swings in Non-Current Deffered Revenue: plummeted 88.5% in 2019 and later soared 311.05% in 2020.
  • TransMedics' Non-Current Deffered Revenue stood at $3.4 million in 2018, then plummeted by 88.5% to $389000.0 in 2019, then soared by 311.05% to $1.6 million in 2020, then rose by 1.06% to $1.6 million in 2021.
  • The last three reported values for Non-Current Deffered Revenue were $1.6 million (Q3 2021), $1.5 million (Q2 2021), and $1.6 million (Q1 2021) per Business Quant data.